Search Results - Kelly L. Harms, MD, PhD

Circulating tumor DNA is a useful adjunct for Merkel cell carcinoma monitoring in the context of multiple metastatic malignancies by Daniel Wenzel, MD, Andrew M. Schuler, MD, David C. Smith, MD, Joseph R. Evans, MD, PhD, Kelly L. Harms, MD, PhD, Elisabeth A. Pedersen, MD, PhD

Connect to this object online.

Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series by Jason M. Rizzo, MD, PhD, Paul W. Harms, MD, PhD, Kelly L. Harms, MD, PhD, Andrew Plaska, MD, Chad Brenner, PhD, Alison B. Durham, MD

Connect to this object online.